Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasmin Mekhail

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Oncology Reports|May 29, 2012
Thymic neoplasms: a clinical updateMark Mikhail, Yasmin Mekhail, Tarek Mekhail
Radiology Case Reports|May 12, 2017
Focal angiomatosis of the breast with MRI and histologic featuresYasmin Mekhail, Andrew Prather, Carolyn Hanna, et al.
Clinical Breast Cancer|April 8, 2018
Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and ManagementR Jared Weinfurtner, Bethany Niell, Yasmin Mekhail, et al.
Archives of Pathology & Laboratory Medicine|September 24, 2021
Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [HER2]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average HER2 Copy Number <4.0)Raza S Hoda, Shabnam Zarei, Patrick J McIntire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Oncology Reports|May 29, 2012
Thymic neoplasms: a clinical updateMark Mikhail, Yasmin Mekhail, Tarek Mekhail
Radiology Case Reports|May 12, 2017
Focal angiomatosis of the breast with MRI and histologic featuresYasmin Mekhail, Andrew Prather, Carolyn Hanna, et al.
Clinical Breast Cancer|April 8, 2018
Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and ManagementR Jared Weinfurtner, Bethany Niell, Yasmin Mekhail, et al.
Archives of Pathology & Laboratory Medicine|September 24, 2021
Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [HER2]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average HER2 Copy Number <4.0)Raza S Hoda, Shabnam Zarei, Patrick J McIntire, et al.
Pageof 1